Parsatuzumab Uses, Dosage, Side Effects and more
Parsatuzumab is under investigation in clinical trial NCT01366131 (Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)).
| Attribute | Details |
|---|---|
| Trade Name | Parsatuzumab |
| Generic | Parsatuzumab |
| Parsatuzumab Other Names | MEGF0444A, Parsatuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
